7 insiders reported 13 Form 4 transactions for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) over the past 18 months (most recent 2026-07-02). Recent activity: Felix Lourdes (Director) Buy 30,000 shares, Pursglove Geordan Garrett (CEO and Chairman of the Board) Buy 350,000 shares, Sawyer Jason David (Director) Buy 40,000 shares, Holloway Michael Andrew (Director) Buy 15,000 shares, Stazzone Peter (Chief Financial Officer) Buy 50,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Felix Lourdes | Director | Buy | 30,000 | $0 |
| 2026-07-02 | Pursglove Geordan Garrett | CEO and Chairman of the Board | Buy | 350,000 | $0 |
| 2026-07-02 | Sawyer Jason David | Director | Buy | 40,000 | $0 |
| 2026-07-02 | Holloway Michael Andrew | Director | Buy | 15,000 | $0 |
| 2026-07-02 | Stazzone Peter | Chief Financial Officer | Buy | 50,000 | $0 |
| 2026-07-02 | Primus Guy Warren | Director | Buy | 15,000 | $0 |
| 2026-06-01 | Porter Stuart D | Director | Buy | 25,000 | $0 |
| 2026-04-17 | Felix Lourdes | Director | Buy | 25,000 | $0 |
| 2026-04-17 | Pursglove Geordan Garrett | CEO and Chairman of the Board | Buy | 350,000 | $0 |
| 2026-04-17 | Sawyer Jason David | Director | Buy | 25,000 | $0 |
| 2026-04-17 | Holloway Michael Andrew | Director | Buy | 25,000 | $0 |
| 2026-04-17 | Stazzone Peter | Chief Financial Officer | Buy | 50,000 | $0 |
| 2026-04-17 | Primus Guy Warren | Director | Buy | 25,000 | $0 |
Source: SEC Form 4 filings · as of 2026-07-02